ROCÍO
ALLER DE LA FUENTE
PROFESORES TITULARES DE UNIVERSIDAD
![Foto de José Luis](/img/nophoto.png)
José Luis
Calleja Panero
Publications dans lesquelles il/elle collabore avec José Luis Calleja Panero (13)
2024
-
Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: results of a Delphi study
Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 337-346
-
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
United European Gastroenterology Journal
-
One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population
United European Gastroenterology Journal
-
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
Hepatology, Vol. 79, Núm. 1, pp. 135-148
-
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Journal of Gastroenterology, Vol. 59, Núm. 7, pp. 586-597
2023
-
AEEH «Consensus about detection and referral of hidden prevalent liver diseases»
Gastroenterologia y Hepatologia, Vol. 46, Núm. 3, pp. 236-247
2022
-
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
Liver International, Vol. 42, Núm. 8, pp. 1783-1792
2021
-
Impacto clínico y económico global de la enfermedad hepática por hígado graso no alcohólico
Revista Española de Enfermedades Digestivas, Vol. 113, Núm. 6, pp. 396-403
2020
-
Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 1, pp. 216-225.e5
-
Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17–25) (Journal of Hepatology (2020) 73(1) (17–25), (S0168827820301276), (10.1016/j.jhep.2020.02.028))
Journal of Hepatology
-
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
Journal of Hepatology, Vol. 73, Núm. 1, pp. 17-25
2018
-
The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity
Alimentary Pharmacology and Therapeutics, Vol. 48, Núm. 11-12, pp. 1260-1270
2017
-
Co-20. Validación de los índices fib 4 y nfs para discriminar fibrosis hepática en pacientes con eghna en práctica clínica habitual.
Revista andaluza de patología digestiva, Vol. 40, Núm. 5, pp. 282-283